Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT
US7851591B1 · kind B1 · utility
1Cited by
5References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 29, 1999 |
| Grant date | Dec 14, 2010 |
| Priority date | — |
| Expiry date | Feb 19, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/5158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for conducting cancer immunotherapy and diagnosis using universal tumor associated antigens, such as the telomerase catalytic subunit (hTERT), and methods for identifying and characterizing universal tumor associated antigens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.